Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 37 matches.
Page:
1
Refine your search to narrow the results.

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009

2016 Sep; 20(5): 375-431. Epub 2016 Jul 15.

Journal
Journal of Cutaneous Medicine and Surgery (JCMS)
PubMed ID
27421294
Condition
Psoriasis
Author
KA Papp, W Gulliver, CW Lynde, Y Poulin, D Adam, B Barankin, K Barber, M Bourcier, M Gooderham, LC Guenther, VC Ho, A Metelitsa, NH Shear, RB Vender, N Wasel, MC Wiseman
Year
2016
Register & Request Access

Phase 3 Trials of Ixekizumab in Moderate-to-severe Plaque Psoriasis

2016 Jul 28; 375(4): 3345-56. Epub 2016 Jun 8. 

Journal
The New England Journal of Medicine
PubMed ID
2729980
Condition
Psoriasis
Author
K.B. Gordon, A. Blauvelt, K.A. Papp, R.G. Langley, T. Luger, M. Ohtsuki, K. Reich, D. Amato, S.G. Ball, D.K. Braun, G.S. Cameron, J. Erickson, R.J. Konrad, T.M. Muram, B.J. Nickoloff, O.O. Osuntokun, R.J. Secrest, F. Zhao, L. Mallbris, C.L. Leonardi
Year
2016
Register & Request Access

Daylight-Mediated Photodynamic Therapy for Actinic Keratosis

2016 Jul/Aug; 8(4): 265-8.

Journal
Journal of the Dermatology Nurses’ Association
Condition
Actinic Keratosis
Author
Lynda Spelman, Teagan Holland, Kurt Davidson
Year
2016
Register & Request Access

Effectiveness of Sequential Use of Biologics in the Treatment of Moderate to Severe Psoriasis in Real World Canadian Academic Clinical Practice: A Cohort Study

2016 Jan; 74(1):176-7.

Journal
Journal of the American Academy of Dermatology
PubMed ID
26702799
Condition
Psoriasis
Author
J.K. Qiang, A. Shahbaz, W. Kim, J. Marinas, S. Greaves, J. Yeung
Year
2016
Register & Request Access

Treatment with Tildrakizumab, an Anti–IL-23p19 Monoclonal Antibody, Improves Health-Related Quality of Life in Patients with Chronic Plaque Psoriasis

Presented at EULAR 2016, London, England, 8-11 June 2016.

Condition
Psoriasis
Author
D Thaçi, K Papp, K Reich, RG Langley, Q Li, A Mehta, C La Rosa
Year
2016
Register & Request Access

A Prospective Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis

2016 Aug; 175(2): 273-86. Epub 2016 Jun 23.

Journal
British Journal of Dermatology
PubMed ID
26914406
Condition
Psoriasis
Author
K.A. Papp, K. Reich, C. Paul, A. Blauvelt, W. Baran, C. Bolduc, D. Toth, R.G. Langley, J. Cather, A.B. Gottlieb, D. Thaci, J.G. Krueger, C.B. Russell, C.E. Milmont, J. Li, P.A. Klekotka, G. Kricorian, A. Nirula
Year
2016
Register & Request Access

Safety and Tolerability of Apremilast Up to 182 weeks: Pooled Analyses From Phase 3 Clinical Trials

Presented at the CDA 91st Annual Meeting, Saskatoon, Saskatchewan, June 2016.

Condition
Psoriasis
Author
Kim Papp, Jeffrey M. Sobell, Kamal Shah, Robert M. Day, Rongdean Chen, Carle Paul
Year
2016
Register & Request Access

52-Week Efficacy and Safety of Apremilast and Switch From Etanercept in Patients With Moderate to Severe Psoriasis: Results From the LIBERATE Study

Presented at the Annual European Congress of Rheumatology EULAR 2016, London, England, June 8-11, 2016.

Condition
Psoriasis
Author
Kristian Reich, Jennifer Soung, Melinda Gooderham, Zuoshun Zhang, Kristine Nograles, Robert M. Day, Laura Ferris, Mark Goodfield
Year
2016
Register & Request Access

Clinician Training in Motivational Communication Skills: The Impact of Derm Connect Canada (Phase 1)

Presented at the 91st CDA Annual Conference, Saskatoon, Saskatchewan, June 22-25, 2016.

Condition
Motivational Communication
Author
Kim Lavoie, Melinda Gooderham, Simon Bacon, Tavis Campbell, Michael Vallis, Catherine Laurin, Anda Dragomir, Kim Papp
Year
2016
Register & Request Access

LIBERATE Trial: Sustained Efficacy of Apremilast in Patients With Nail and Scalp Psoriasis Who Continued on Apremilast or Switched From Etanercept

Presented at the 91st CDA Annual Conference, Saskatoon, Saskatchewan, June 22-25, 2016.

Condition
Nail and Scalp Psoriasis
Author
Melinda Gooderham, Zuoshun Zhang, Robert M. Day, Laura Ferris
Year
2016
Register & Request Access
Page:
1

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login